What is she best known for?
The fields of study she is best known for:
Her primary areas of investigation include Cell biology, Immunology, Genetic enhancement, Haematopoiesis and Virology.
Her Cell biology research is multidisciplinary, relying on both Dendritic cell, Interferon gamma, Interleukin 12, Bone marrow and Transplantation.
The Immunology study combines topics in areas such as Progenitor cell and Molecular biology.
She has included themes like Gene targeting and Viral vector in her Genetic enhancement study.
Her study explores the link between Viral vector and topics such as Wiskott–Aldrich syndrome protein that cross with problems in Knockout mouse.
Her Haematopoiesis research integrates issues from Regulation of gene expression, Mutant and Transduction.
Her most cited work include:
- Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome (742 citations)
- Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset (606 citations)
- Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. (571 citations)
What are the main themes of her work throughout her whole career to date?
Anne Galy mainly investigates Cell biology, Genetic enhancement, Haematopoiesis, Immunology and Stem cell.
Her studies deal with areas such as Cellular differentiation, CD40, Antigen-presenting cell, Dendritic cell and Interleukin 12 as well as Cell biology.
The study incorporates disciplines such as Cancer research, Virology, Wiskott–Aldrich syndrome, Viral vector and Transduction in addition to Genetic enhancement.
Her biological study spans a wide range of topics, including Progenitor cell, CD34, Endothelial stem cell and Molecular biology.
Her research in Immunology focuses on subjects like Transplantation, which are connected to Knockout mouse and Gene.
The various areas that Anne Galy examines in her Stem cell study include Fanconi anemia, Bone marrow and Lymphocyte.
She most often published in these fields:
- Cell biology (50.00%)
- Genetic enhancement (39.20%)
- Haematopoiesis (34.09%)
What were the highlights of her more recent work (between 2016-2019)?
- Genetic enhancement (39.20%)
- Cell biology (50.00%)
- Haematopoiesis (34.09%)
In recent papers she was focusing on the following fields of study:
Genetic enhancement, Cell biology, Haematopoiesis, Viral vector and Transduction are her primary areas of study.
Her research in Genetic enhancement intersects with topics in Hematopoietic stem cell transplantation, Cancer research, Wiskott–Aldrich syndrome and Prospective cohort study.
Her Cell biology research is multidisciplinary, incorporating elements of Gene transfer, Transgene, Dose dependence and Immune system.
Her work in Haematopoiesis addresses issues such as Fanconi anemia, which are connected to fields such as Bone marrow failure.
Her research in Viral vector tackles topics such as Gene delivery which are related to areas like Lung tissue, Lung and Drug.
She interconnects Cell, Progenitor cell, Protein domain, Enhancer and Hematopoietic stem cell in the investigation of issues within Transduction.
Between 2016 and 2019, her most popular works were:
- Safety of rAAV2/2-ND4 Gene Therapy for Leber Hereditary Optic Neuropathy. (43 citations)
- Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult. (42 citations)
- Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia. (40 citations)
In her most recent research, the most cited papers focused on:
Anne Galy mainly focuses on Genetic enhancement, Haematopoiesis, Viral vector, Cancer research and Hematopoietic stem cell transplantation.
Her work carried out in the field of Genetic enhancement brings together such families of science as LEBER HEREDITARY OPTIC NEUROPATHY, Electroretinography, MEDLINE and Bioinformatics.
The study incorporates disciplines such as Cell culture, Progenitor cell, CD34, Molecular biology and Transduction in addition to Haematopoiesis.
She combines subjects such as Myeloid, Kidney disease and Cell biology with her study of Viral vector.
The concepts of her Cancer research study are interwoven with issues in Bone marrow failure, FANCA, Stem cell, Bone marrow and In vivo.
Her studies in Hematopoietic stem cell transplantation integrate themes in fields like Fanconi anemia, Immunosuppression, Immunology, Wiskott–Aldrich syndrome and Acute leukemia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
